{"nct_id":"NCT01350804","title":"Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1)","status":"COMPLETED","status_verified_date":"2016-05","start_date":"2011-09","start_date_type":null,"primary_completion_date":"2015-02","primary_completion_date_type":"ACTUAL","completion_date":"2015-02","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}